PO Box 1488
Warrenville, IL 60555
Phone: 331.248.7888
Email: sidp@affinity-strategies.com
Dr. Mike Dudley (@MikeMndudley), President and CEO of Qpex Biopharma, joins Dr. Erin McCreary (@erinmccreary) to discuss the thrills and failures of antibiotic discovery and development along with the critical need for antibiotic market reform. We discuss the complexity of antibiotic resistance in gram-negative pathogens, antibiotic targets, potential market solutions, and more!
Mike Dudley PharmD, FIDSA
Mike Dudley is the President and CEO of Qpex Biopharma. Mike has more than 40 years of experience in anti-infective research, development and commercialization. He is a fellow of the Infectious Diseases Society of America (FIDSA). Prior to his career in industry, Mike held academic appointments at the University of Rhode Island College of Pharmacy and Brown University School of Medicine in Providence, Rhode Island. He has published more than 160 scientific papers and book chapters on the discovery, preclinical/clinical evaluation and use of anti-infectives. Mike completed undergraduate work in biology at Pepperdine University in Malibu, California. He earned a Doctor of Pharmacy and completed his residency at the University of California, San Francisco (UCSF). Mike completed a fellowship in infectious disease at Hartford Hospital in Hartford, Connecticut.
